rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
4	Chronic sciatica	C0036396	3	26	1.3912804242011134e-10	7.93650793651e-06	ADRA1A,ADRA2A,ADRA2C
5	Hypotension	C0020649	4	129	5.069910047339476e-10	9.92063492063e-06	ADRA1A,ADRA1B,ADRA2A,ALB
6	Acute disease of cardiovascular system	C0001314	3	38	6.811580188781363e-10	1.19047619048e-05	ADRA1A,ADRA2A,ADRA2C
7	Low back pain	C0024031	3	41	9.462928218795241e-10	1.38888888889e-05	ADRA1A,ADRA2A,ADRA2C
8	Low Tension Glaucoma	C0152136	3	54	2.8208468894064254e-09	1.5873015873e-05	ADRA1A,ADRA2A,ADRA2C
11	Systemic arterial pressure	C1272641	4	442	2.405281516182356e-07	2.18253968254e-05	ADRA1A,ADRA1B,ADRA2A,ADRA2C
12	Gastroparesis	C0152020	2	36	2.554776956653626e-07	2.38095238095e-05	ADRA1A,ADRA1B
13	Nephrosclerosis	C0027719	2	38	3.0179326193646716e-07	2.57936507937e-05	ADRA1A,ALB
14	Hyperalgesia	C0020429	3	177	3.4423882144807294e-07	2.77777777778e-05	ADRA1A,ADRA2A,ADRA2C
15	Learning Disabilities	C0751265	2	40	3.532812249407158e-07	2.97619047619e-05	ADRA2A,ADRA2C
24	Fibrosis	C0016059	3	191	4.669076250074511e-07	4.7619047619e-05	ADRA2A,ADRA2C,ALB
25	Attention deficit hyperactivity disorder	C1263846	4	527	5.748312379427745e-07	4.96031746032e-05	ADRA1A,ADRA1B,ADRA2A,ADRA2C
37	Pain	C0030193	4	628	1.365977911005345e-06	7.34126984127e-05	ADRA1A,ADRA2A,ADRA2C,ALB
40	Acute Lung Injury	C0242488	2	71	2.031940840474533e-06	7.93650793651e-05	ADRA2A,ALB
41	Cardiomegaly	C0018800	3	279	2.1157782782443846e-06	8.13492063492e-05	ADRA1B,ADRA2A,ADRA2C
44	Essential hypertension	C0085580	3	305	3.0141903132330228e-06	8.73015873016e-05	ADRA1A,ADRA1B,ALB
48	Mood Disorders	C0525045	3	322	3.737787836688433e-06	9.52380952381e-05	ADRA1B,ADRA2A,ADRA2C
51	Neuralgia	C0027796	2	94	4.745038666209567e-06	0.00010119047619	ADRA2A,ADRA2C
54	Methamphetamine abuse	C0013146	2	105	6.622202782580189e-06	0.000107142857143	ADRA1A,ALB
62	Hypertension	C0020538	5	1647	7.083948260766526e-06	0.000123015873016	ADRA1A,ADRA1B,ADRA2A,ADRA2C,ALB
68	Tourette Syndrome	C0040517	2	131	1.2871761454369413e-05	0.000134920634921	ADRA1A,ADRA2A
75	Polycystic Ovary Syndrome	C0032460	3	477	1.7644551179696322e-05	0.00014880952381	ADRA1A,ADRA1B,ALB
79	Major depressive disorder	C1269683	3	489	1.9454900149651344e-05	0.000156746031746	ADRA1A,ADRA2A,ADRA2C
85	Irritable bowel syndrome with diarrhea	C0022104	2	162	2.4309290310386977e-05	0.000168650793651	ADRA2A,ADRA2C
91	Obstructive sleep apnea	C0520679	2	166	2.6146980754426785e-05	0.000180555555556	ADRA1B,ADRA2A
92	Depressive Disorder	C0011581	3	543	2.9347880630470335e-05	0.00018253968254	ADRA2A,ADRA2C,ALB
97	Familial hypercholesterolemia	C0020445	2	182	3.4411672557022044e-05	0.00019246031746	ADRA1A,ALB
98	 Acrodysostosis 1, with or without hormone resistance, 101800 (3)	C0220659	1	25	3.7022609550851904e-05	0.000194444444444	ADRA1A
99	Pseudohypoparathyroidism, type IB, 603233 (3)	C1864100	1	25	3.7022609550851904e-05	0.000196428571429	ADRA1A
100	Malignant neoplasm of adrenal cortex	C0346402	1	26	4.010006489596485e-05	0.000198412698413	ALB
101	Behavior Disorders	C0004930	1	27	4.329969676541978e-05	0.000200396825397	ADRA2A
102	Esophageal varix	C0014867	1	27	4.329969676541978e-05	0.000202380952381	ALB
103	Disorders of parathyroid gland	C0030517	1	27	4.329969676541978e-05	0.000204365079365	ADRA1A
104	Urolithiasis	C0451641	1	27	4.329969676541978e-05	0.000206349206349	ALB
105	genetic hypertension	C0598428	1	27	4.329969676541978e-05	0.000208333333333	ADRA1A
106	Echinococcosis	C0013502	1	28	4.662131558863525e-05	0.000210317460317	ALB
107	Hereditary Sensory Autonomic Neuropathy, Type 1	C0020071	1	28	4.662131558863525e-05	0.000212301587302	ADRA1A
108	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	1	28	4.662131558863525e-05	0.000214285714286	KRT9
109	Palmar hyperkeratosis	C0240641	1	28	4.662131558863525e-05	0.00021626984127	KRT9
110	Kidney Failure, Chronic	C0022661	3	616	4.807552400665216e-05	0.000218253968254	ADRA1A,ADRA1B,ALB
111	Bladder neck obstruction	C0005694	1	29	5.0065109443941935e-05	0.000220238095238	ADRA1A
112	Proliferative retinopathy	C0339467	1	29	5.0065109443941935e-05	0.000222222222222	ALB
113	Verrucae	C0043037	1	30	5.363080417897237e-05	0.000224206349206	KRT9
114	Taste bitter	C0235290	1	30	5.363080417897237e-05	0.00022619047619	ADRA1A
115	Isolated somatotropin deficiency	C3714796	1	30	5.363080417897237e-05	0.000228174603175	ALB
116	Metabolic Syndrome X	C0524620	3	638	5.513363217024558e-05	0.000230158730159	ADRA1A,ADRA2A,ALB
117	Substance Use Disorders	C0038586	1	31	5.731835511657568e-05	0.000232142857143	ALB
118	Dentatorubral pallidoluysian atrophy	C0751781	1	31	5.731835511657568e-05	0.000234126984127	ALB
119	Angiokeratoma	C0002985	1	32	6.112771914279502e-05	0.000236111111111	ALB
120	Isolated growth hormone deficiency type 1B	C0013338	1	32	6.112771914279502e-05	0.000238095238095	ALB
121	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	6.112771914279502e-05	0.000240079365079	ADRA2A
122	Congenital long QT syndrome	C1141890	1	32	6.112771914279502e-05	0.000242063492063	ADRA1A
123	Plantar hyperkeratosis	C1856954	1	32	6.112771914279502e-05	0.000244047619048	KRT9
124	Epilepsy	C0014544	3	673	6.789501226855954e-05	0.000246031746032	ADRA1A,ADRA2A,ALB
125	Pericardial effusion	C0031039	1	34	6.911165445966372e-05	0.000248015873016	ALB
126	Excessive salivation	C0037036	1	34	6.911165445966372e-05	0.00025	ADRA2A
127	Pulmonary Cystic Fibrosis	C0392164	1	34	6.911165445966372e-05	0.000251984126984	ADRA1A
128	Mumps	C0026780	1	35	7.328605057499438e-05	0.000253968253968	ALB
129	Rhinitis, Allergic, Perennial	C0035457	1	35	7.328605057499438e-05	0.000255952380952	ALB
130	Endemic Cretinism	C0342200	1	35	7.328605057499438e-05	0.000257936507937	ALB
131	Hemangioblastoma	C0206734	1	36	7.758197107710085e-05	0.000259920634921	ALB
132	Chronic schizophrenia	C0221765	1	36	7.758197107710085e-05	0.000261904761905	ADRA1A
133	Hypoparathyroidism - autosomal dominant	C0342345	1	36	7.758197107710085e-05	0.000263888888889	ADRA1A
134	Acute postoperative pain	C0030201	1	37	8.199939989705918e-05	0.000265873015873	ADRA1A
135	Mesangiocapillary glomerulonephritis, type II	C0017662	1	38	8.653814902703783e-05	0.000267857142857	ALB
136	Peripheral motor neuropathy	C0235025	1	38	8.653814902703783e-05	0.000269841269841	ALB
137	Paroxysmal atrial fibrillation	C0235480	1	38	8.653814902703783e-05	0.000271825396825	ADRA1A
138	End Stage Liver Disease	C0745744	1	38	8.653814902703783e-05	0.00027380952381	ALB
139	Cholestasis of pregnancy	C0268318	1	39	9.119820476088947e-05	0.000275793650794	ADRA1A
140	Abnormal albumin level	C4023036	1	39	9.119820476088947e-05	0.000277777777778	ALB
141	Neurotoxicity Syndromes	C0235032	1	40	9.597949397144312e-05	0.000279761904762	ADRA1B
142	Acth-Independent Macronodular Adrenal Hyperplasia	C1857451	1	40	9.597949397144312e-05	0.000281746031746	ADRA2A
143	Bronchogenic Carcinoma	C0007121	1	41	0.0001008820307765168	0.00028373015873	ALB
144	Nephrogenic diabetes insipidus, autosomal	C0162283	1	42	0.00010590557092893249	0.000285714285714	ADRA1A
145	Coronary artery aneurysm	C0010051	1	43	0.00011105021506507828	0.000287698412698	ALB
146	Hyperlipoproteinemia	C0020476	1	43	0.00011105021506507828	0.000289682539683	ALB
147	Hyperlipoproteinemia Type IIa	C0745103	1	43	0.00011105021506507828	0.000291666666667	ALB
148	Tubulointerstitial nephritis	C0027707	1	44	0.00011631577408433014	0.000293650793651	ALB
149	Single tumor	C1298180	1	44	0.00011631577408433014	0.000295634920635	ALB
150	Nephrotic Syndrome, Minimal Change	C1704321	1	44	0.00011631577408433014	0.000297619047619	ALB
151	Congestive heart failure	C0018802	3	782	0.00012165453923695946	0.000299603174603	ADRA1A,ADRA2C,ALB
152	Drug usage	C0242510	1	45	0.00012170223540242109	0.000301587301587	ADRA2A
153	Skin Diseases, Genetic	C0037277	1	46	0.00012720943961064268	0.000303571428571	KRT9
154	Weight Loss Adverse Event	C2911645	1	46	0.00012720943961064268	0.000305555555556	ADRA2A
155	Varicella zoster	C0740380	1	47	0.00013283745710790384	0.00030753968254	ALB
156	Drusen	C1260959	1	47	0.00013283745710790384	0.000309523809524	ALB
157	Heart Failure	C0018801	3	803	0.00013480418347744383	0.000311507936508	ADRA1A,ADRA2C,ALB
158	Fibromyalgia	C0016053	1	48	0.00013858616155659753	0.000313492063492	ADRA1A
159	Increased antibody level in blood	C0151669	1	48	0.00013858616155659753	0.000315476190476	KRT9
160	Insulin resistance syndrome	C3714619	1	48	0.00013858616155659753	0.00031746031746	ALB
161	Dyskinesia, Drug-Induced	C0013386	1	49	0.0001444555074693321	0.000319444444444	ADRA1A
162	Polydipsia	C0085602	1	49	0.0001444555074693321	0.000321428571429	ADRA2A
163	Nephrosis	C0027720	1	51	0.00015655557724270075	0.000323412698413	ALB
164	Spondylitis, Ankylosing	C0038012	1	51	0.00015655557724270075	0.000325396825397	ADRA1B
165	Guillain-Barre syndrome, familial	C0018378	1	52	0.0001627862729773888	0.000327380952381	ALB
166	Primary hyperparathyroidism	C0221002	1	53	0.00016913726443912314	0.000329365079365	ALB
167	Drug Resistant Epilepsy	C1096063	1	53	0.00016913726443912314	0.000331349206349	ALB
168	Acute Coronary Syndrome	C0948089	2	320	0.00018356972345789924	0.000333333333333	ADRA2A,ALB
169	Memory Disorders	C0025261	1	56	0.00018891155800093706	0.000335317460317	ADRA1A
170	Respiratory Tract Diseases	C0035242	1	56	0.00018891155800093706	0.000337301587302	ALB
171	Sicca Syndrome	C0086981	1	56	0.00018891155800093706	0.000339285714286	ALB
172	Hypoalbuminemia	C0239981	1	56	0.00018891155800093706	0.00034126984127	ALB
173	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	1	57	0.00019574315918213792	0.000343253968254	ALB
174	Abnormality of the plantar skin of foot	C4020946	1	57	0.00019574315918213792	0.000345238095238	KRT9
175	Inflammatory pain	C0234251	1	58	0.00020269464085753697	0.000347222222222	ADRA1A
176	Congenital hypothyroidism	C0010308	1	60	0.00021695741424831994	0.000349206349206	ALB
177	Adverse drug events and drug allergies	C0041755	1	60	0.00021695741424831994	0.00035119047619	ALB
178	Hypogonadism with anosmia	C0162809	1	61	0.00022426844786382905	0.000353174603175	ADRA1A
179	Liver Cirrhosis, Biliary	C0023890	3	919	0.0002269601149228473	0.000355158730159	ADRA1A,ADRA2A,ALB
180	Hemolytic uremic syndrome	C0019061	1	65	0.00025470873897770474	0.000357142857143	ALB
181	Psychoses, Substance-Induced	C0033941	1	66	0.0002626174780610002	0.000359126984127	ADRA2C
182	Attention Deficit Disorder	C0041671	1	66	0.0002626174780610002	0.000361111111111	ADRA2A
183	Occupational Diseases	C0028797	1	68	0.0002787929616050455	0.000363095238095	ALB
184	Microalbuminuria	C0730345	1	68	0.0002787929616050455	0.000365079365079	ALB
185	Thyroid Diseases	C0040128	2	376	0.00029508664938293627	0.000367063492063	ADRA1B,ALB
186	Chest pain	C0008031	1	70	0.00029544518225488314	0.000369047619048	ALB
187	Urinary incontinence	C0042024	1	70	0.00029544518225488314	0.000371031746032	ADRA1A
188	 {HIV-1 viremia, susceptibility to}, 609423 (3)	C0042749	1	71	0.000303949895835931	0.000373015873016	ALB
189	Anxiety Disorders	C0003469	2	383	0.0003115113047734708	0.000375	ADRA1A,ADRA2A
190	Heart Diseases	C0018799	2	386	0.00031872834737634026	0.000376984126984	ADRA2A,ALB
191	Blood pressure finding	C1271104	2	386	0.00031872834737634026	0.000378968253968	ADRA1B,ADRA2A
192	Complications of Diabetes Mellitus	C0342257	1	75	0.00033915794784322717	0.000380952380952	ALB
193	Diabetes mellitus type 2	C0011860	4	1972	0.0003473073766401269	0.000382936507937	ADRA1A,ADRA2A,ADRA2C,ALB
194	Pulmonary edema	C0034063	1	77	0.00035747443793265887	0.000384920634921	ALB
195	Ichthyosis bullosa of Siemens	C0432306	1	77	0.00035747443793265887	0.000386904761905	ADRA2A
196	Stevens-Johnson Syndrome	C0038325	1	78	0.00036681062194965364	0.000388888888889	ALB
197	Unipolar Depression	C0041696	2	406	0.0003696311139128605	0.000390873015873	ADRA2A,ADRA2C
198	Lymphohistiocytosis, Hemophagocytic	C0024291	1	80	0.00038583836510885927	0.000392857142857	ALB
